Please login to the form below

Not currently logged in
Email:
Password:

plaque psoriasis

This page shows the latest plaque psoriasis news and features for those working in and with pharma, biotech and healthcare.

AbbVie and Boehringer’s psoriasis drug Skyrizi gets CHMP nod

AbbVie and Boehringer’s psoriasis drug Skyrizi gets CHMP nod

Skyrizi is one of the new class of interleukin-23 (IL-23) inhibitor, for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy. ... The CHMP positive opinion is supported by data from the global

Latest news

More from news
Approximately 6 fully matching, plus 82 partially matching documents found.

Latest Intelligence

  • Pharma deals continue to slide Pharma deals continue to slide

    Pre-registration (US) topical high potency steroid for moderate to severe plaque psoriasis.

  • 'Nothing about us without us' 'Nothing about us without us'

    Similarly, Novartis - which issued a patient declaration committing, among other things, to inviting patient input early on in their clinical trial process - recently invited people living with plaque psoriasis to attend

  • Deal Watch March 2017 Deal Watch March 2017

    Merck KGaA has partnered its product M1095 (ALX-0761), for plaque psoriasis, to Avillion.

  • Deal Watch July 2016 Deal Watch July 2016

    The product completed Phase 3 studies in moderate to severe plaque psoriasis in May 2016 and announced that the primary endpoints had been met. ... Acquisition. 78. Sun Pharma/ Almirall. Tildrakizumab (IL-23p19 inhibitor) - psoriasis. Licence.

  • Deal Watch March 2016 Deal Watch March 2016

    Two deals involved products at a later stage of development: Dr Reddy's licence for Xenoport's phase II product XP23829 for plaque psoriasis, and Ipsen's licence for Exelixis's ... Collaboration – development. $595. Xenoport/ Dr Reddy's. XP-23829 for

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics